Citation: D. Saha et al., Oncogenic Ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4, J BIOL CHEM, 276(31), 2001, pp. 29531-29537
Authors:
Fujimoto, K
Sheng, H
Shao, J
Beauchamp, RD
Citation: K. Fujimoto et al., Transforming growth factor-beta 1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells, EXP CELL RE, 266(2), 2001, pp. 239-249
Authors:
Deane, NG
Parker, MA
Aramandla, R
Diehl, L
Lee, WJ
Washington, MK
Nanney, LB
Shyr, Y
Beauchamp, RD
Citation: Ng. Deane et al., Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice, CANCER RES, 61(14), 2001, pp. 5389-5395
Authors:
Jol, H
Zhang, R
Zhang, H
McKinsey, TA
Shao, JY
Beauchamp, RD
Ballard, DW
Liang, P
Citation: H. Jol et al., NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis, ONCOGENE, 19(7), 2000, pp. 841-849
Authors:
Talamonti, MS
Catalano, PJ
Vaughn, DJ
Whittington, R
Beauchamp, RD
Berlin, J
Benson, AB
Citation: Ms. Talamonti et al., Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapyin patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity, J CL ONCOL, 18(19), 2000, pp. 3384-3389
Authors:
Fujimoto, K
Hosotani, R
Miyamoto, Y
Doi, R
Koshiba, T
Otaka, A
Fujii, N
Beauchamp, RD
Imamura, M
Citation: K. Fujimoto et al., Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells, CANCER LETT, 159(2), 2000, pp. 151-158
Authors:
Sheng, HM
Shao, JY
Dixon, DA
Williams, CS
Prescott, SM
DuBois, RN
Beauchamp, RD
Citation: Hm. Sheng et al., Transforming growth factor-beta 1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA, J BIOL CHEM, 275(9), 2000, pp. 6628-6635
Authors:
Scoggins, CR
Meszoely, IM
Blanke, CD
Beauchamp, RD
Leach, SD
Citation: Cr. Scoggins et al., Nonoperative management of primary colorectal cancer in patients with stage IV disease, ANN SURG O, 6(7), 1999, pp. 651-657
Authors:
Sheng, HM
Shao, JY
O'Mahony, CA
Lamps, L
Albo, D
Isakson, PC
Berger, DH
DuBois, RN
Beauchamp, RD
Citation: Hm. Sheng et al., Transformation of intestinal epithelial cells by chronic TGF-beta 1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2, ONCOGENE, 18(4), 1999, pp. 855-867
Authors:
Delbeke, D
Rose, DM
Chapman, WC
Pinson, CW
Wright, JK
Beauchamp, RD
Shyr, Y
Leach, SD
Citation: D. Delbeke et al., Optimal interpretation of FDG PET in the diagnosis, staging and managementof pancreatic carcinoma, J NUCL MED, 40(11), 1999, pp. 1784-1791
Authors:
Shao, JY
Sheng, HM
Aramandla, R
Pereira, MA
Lubet, RA
Hawk, E
Grogan, L
Kirsch, IR
Washington, MK
Beauchamp, RD
DuBois, RN
Citation: Jy. Shao et al., Coordinate regulation of cyclooxygenase-2 and TGF-beta 1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors, CARCINOGENE, 20(2), 1999, pp. 185-191
Authors:
O'Mahony, CA
Beauchamp, RD
Albo, D
Tsujii, M
Sheng, HM
Shao, J
Dubois, RN
Berger, DH
Citation: Ca. O'Mahony et al., Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis, SURGERY, 126(2), 1999, pp. 364-370
Authors:
Rose, DM
Delbeke, D
Beauchamp, RD
Chapman, WC
Sandler, MP
Sharp, KW
Richards, WO
Wright, JK
Frexes, ME
Pinson, CW
Leach, SD
Citation: Dm. Rose et al., (18)fluorodeoxyglucose positron emission tomography in the management of patients with suspected pancreatic cancer, ANN SURG, 229(5), 1999, pp. 729-738